Using light to control genome editing
New technique offers precise manipulation of when and where genes are targeted.
Harvard-MIT Health Sciences and Technology
J-WAFS Solutions program awards $750,000 in commercialization grants
Four new projects and one renewal receive $150,000 in funding for 2016-2017.
Study sheds light on role of mutations in metastasized cancer
Researchers identify genes that mutate in endometrial cancer, create a family tree describing the evolutionary history of the disease.
Thirteen MIT students awarded National Defense Science and Engineering Graduate Fellowships
Honor recognizes individuals who have demonstrated ability and special aptitude for advanced training in science and engineering.
Five from MIT win 2016 Paul and Daisy Soros Fellowships for New Americans
Awards fund graduate studies for immigrants and children of immigrants.
Good medicine
Varesh Prasad, an MIT graduate student in health sciences and technology, is creating a multidisciplinary future in health care.
Seven from MIT elected to American Academy of Arts and Sciences for 2016
Prestigious honor society announces 213 new members this year.
Implantable device targets pancreatic cancer
Chemotherapy delivered directly to tumors may slow the disease.
25 from MIT named to Forbes 30 Under 30 lists in 2016
Students, researchers, and alumni honored in the 2016 Forbes 30 Under 30 lists showcasing America’s most important young entrepreneurs, thinkers, and leaders.
Four MIT faculty named 2015 fellows of the National Academy of Inventors
Belcher, Bhatia, Brown, and Horvitz recognized for demonstrating a prolific spirit of innovation and invention resulting in a tangible impact on society.
Scientists discover how cancer cells escape blood vessels
Study offers new targets for drugs that may prevent cancer from spreading.
Taking many forms of expertise to heart
Elazer Edelman’s multidisciplinary teams bring innovation to cardiovascular health worldwide.
A new way to deliver microRNAs for cancer treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
Turbocharging medical translation
Jeff Karp’s diverse multidisciplinary team brings novel solutions to a wide array of health challenges.